Drug-resistant tuberculosis: Time for visionary political leadership

Ibrahim Abubakar, Matteo Zignol, Dennis Falzon, Mario Raviglione, Lucica Ditiu, Susan Masham, Ifedayo Adetifa, Nathan Ford, Helen Cox, Stephen D. Lawn, Ben J. Marais, Timothy D. McHugh, Peter Mwaba, Matthew Bates, Marc Lipman, Lynn Zijenah, Simon Logan, Ruth McNerney, Adam Zumla, Krishna SardaPayam Nahid, Michael Hoelscher, Michel Pletschette, Ziad A. Memish, Peter Kim, Richard Hafner, Stewart Cole, Giovanni Battista Migliori, Markus Maeurer, Marco Schito, Alimuddin Zumla

Research output: Contribution to journalArticle

187 Citations (Scopus)

Abstract

Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly cost-effective directly observed treatment short-course programme to control the epidemic. At that time, most strains of Mycobacterium tuberculosis were susceptible to first-line tuberculosis drugs, and drug resistance was not a major issue. However, in 2013, tuberculosis remains a major public health concern worldwide, with prevalence of multidrug-resistant (MDR) tuberculosis rising. WHO estimates roughly 630 000 cases of MDR tuberculosis worldwide, with great variation in the frequency of MDR tuberculosis between countries. In the past 8 years, extensively drug-resistant (XDR) tuberculosis has emerged, and has been reported in 84 countries, heralding the possibility of virtually untreatable tuberculosis. Increased population movement, the continuing HIV pandemic, and the rise in MDR tuberculosis pose formidable challenges to the global control of tuberculosis. We provide an overview of the global burden of drug-resistant disease; discuss the social, health service, management, and control issues that fuel and sustain the epidemic; and suggest specific recommendations for important next steps. Visionary political leadership is needed to curb the rise of MDR and XDR tuberculosis worldwide, through sustained funding and the implementation of global and regional action plans.

Original languageEnglish
Pages (from-to)529-539
Number of pages11
JournalThe Lancet Infectious Diseases
Volume13
Issue number6
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Multidrug-Resistant Tuberculosis
Tuberculosis
Extensively Drug-Resistant Tuberculosis
Pandemics
Social Work
Mycobacterium tuberculosis
Drug Resistance
Pharmaceutical Preparations
Health Services
Emergencies
Public Health
HIV
Costs and Cost Analysis
Population

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Abubakar, I., Zignol, M., Falzon, D., Raviglione, M., Ditiu, L., Masham, S., ... Zumla, A. (2013). Drug-resistant tuberculosis: Time for visionary political leadership. The Lancet Infectious Diseases, 13(6), 529-539. https://doi.org/10.1016/S1473-3099(13)70030-6

Drug-resistant tuberculosis : Time for visionary political leadership. / Abubakar, Ibrahim; Zignol, Matteo; Falzon, Dennis; Raviglione, Mario; Ditiu, Lucica; Masham, Susan; Adetifa, Ifedayo; Ford, Nathan; Cox, Helen; Lawn, Stephen D.; Marais, Ben J.; McHugh, Timothy D.; Mwaba, Peter; Bates, Matthew; Lipman, Marc; Zijenah, Lynn; Logan, Simon; McNerney, Ruth; Zumla, Adam; Sarda, Krishna; Nahid, Payam; Hoelscher, Michael; Pletschette, Michel; Memish, Ziad A.; Kim, Peter; Hafner, Richard; Cole, Stewart; Migliori, Giovanni Battista; Maeurer, Markus; Schito, Marco; Zumla, Alimuddin.

In: The Lancet Infectious Diseases, Vol. 13, No. 6, 06.2013, p. 529-539.

Research output: Contribution to journalArticle

Abubakar, I, Zignol, M, Falzon, D, Raviglione, M, Ditiu, L, Masham, S, Adetifa, I, Ford, N, Cox, H, Lawn, SD, Marais, BJ, McHugh, TD, Mwaba, P, Bates, M, Lipman, M, Zijenah, L, Logan, S, McNerney, R, Zumla, A, Sarda, K, Nahid, P, Hoelscher, M, Pletschette, M, Memish, ZA, Kim, P, Hafner, R, Cole, S, Migliori, GB, Maeurer, M, Schito, M & Zumla, A 2013, 'Drug-resistant tuberculosis: Time for visionary political leadership', The Lancet Infectious Diseases, vol. 13, no. 6, pp. 529-539. https://doi.org/10.1016/S1473-3099(13)70030-6
Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S et al. Drug-resistant tuberculosis: Time for visionary political leadership. The Lancet Infectious Diseases. 2013 Jun;13(6):529-539. https://doi.org/10.1016/S1473-3099(13)70030-6
Abubakar, Ibrahim ; Zignol, Matteo ; Falzon, Dennis ; Raviglione, Mario ; Ditiu, Lucica ; Masham, Susan ; Adetifa, Ifedayo ; Ford, Nathan ; Cox, Helen ; Lawn, Stephen D. ; Marais, Ben J. ; McHugh, Timothy D. ; Mwaba, Peter ; Bates, Matthew ; Lipman, Marc ; Zijenah, Lynn ; Logan, Simon ; McNerney, Ruth ; Zumla, Adam ; Sarda, Krishna ; Nahid, Payam ; Hoelscher, Michael ; Pletschette, Michel ; Memish, Ziad A. ; Kim, Peter ; Hafner, Richard ; Cole, Stewart ; Migliori, Giovanni Battista ; Maeurer, Markus ; Schito, Marco ; Zumla, Alimuddin. / Drug-resistant tuberculosis : Time for visionary political leadership. In: The Lancet Infectious Diseases. 2013 ; Vol. 13, No. 6. pp. 529-539.
@article{4340c6a46aea4fd1885ca6a6e0074a47,
title = "Drug-resistant tuberculosis: Time for visionary political leadership",
abstract = "Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly cost-effective directly observed treatment short-course programme to control the epidemic. At that time, most strains of Mycobacterium tuberculosis were susceptible to first-line tuberculosis drugs, and drug resistance was not a major issue. However, in 2013, tuberculosis remains a major public health concern worldwide, with prevalence of multidrug-resistant (MDR) tuberculosis rising. WHO estimates roughly 630 000 cases of MDR tuberculosis worldwide, with great variation in the frequency of MDR tuberculosis between countries. In the past 8 years, extensively drug-resistant (XDR) tuberculosis has emerged, and has been reported in 84 countries, heralding the possibility of virtually untreatable tuberculosis. Increased population movement, the continuing HIV pandemic, and the rise in MDR tuberculosis pose formidable challenges to the global control of tuberculosis. We provide an overview of the global burden of drug-resistant disease; discuss the social, health service, management, and control issues that fuel and sustain the epidemic; and suggest specific recommendations for important next steps. Visionary political leadership is needed to curb the rise of MDR and XDR tuberculosis worldwide, through sustained funding and the implementation of global and regional action plans.",
author = "Ibrahim Abubakar and Matteo Zignol and Dennis Falzon and Mario Raviglione and Lucica Ditiu and Susan Masham and Ifedayo Adetifa and Nathan Ford and Helen Cox and Lawn, {Stephen D.} and Marais, {Ben J.} and McHugh, {Timothy D.} and Peter Mwaba and Matthew Bates and Marc Lipman and Lynn Zijenah and Simon Logan and Ruth McNerney and Adam Zumla and Krishna Sarda and Payam Nahid and Michael Hoelscher and Michel Pletschette and Memish, {Ziad A.} and Peter Kim and Richard Hafner and Stewart Cole and Migliori, {Giovanni Battista} and Markus Maeurer and Marco Schito and Alimuddin Zumla",
year = "2013",
month = "6",
doi = "10.1016/S1473-3099(13)70030-6",
language = "English",
volume = "13",
pages = "529--539",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "6",

}

TY - JOUR

T1 - Drug-resistant tuberculosis

T2 - Time for visionary political leadership

AU - Abubakar, Ibrahim

AU - Zignol, Matteo

AU - Falzon, Dennis

AU - Raviglione, Mario

AU - Ditiu, Lucica

AU - Masham, Susan

AU - Adetifa, Ifedayo

AU - Ford, Nathan

AU - Cox, Helen

AU - Lawn, Stephen D.

AU - Marais, Ben J.

AU - McHugh, Timothy D.

AU - Mwaba, Peter

AU - Bates, Matthew

AU - Lipman, Marc

AU - Zijenah, Lynn

AU - Logan, Simon

AU - McNerney, Ruth

AU - Zumla, Adam

AU - Sarda, Krishna

AU - Nahid, Payam

AU - Hoelscher, Michael

AU - Pletschette, Michel

AU - Memish, Ziad A.

AU - Kim, Peter

AU - Hafner, Richard

AU - Cole, Stewart

AU - Migliori, Giovanni Battista

AU - Maeurer, Markus

AU - Schito, Marco

AU - Zumla, Alimuddin

PY - 2013/6

Y1 - 2013/6

N2 - Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly cost-effective directly observed treatment short-course programme to control the epidemic. At that time, most strains of Mycobacterium tuberculosis were susceptible to first-line tuberculosis drugs, and drug resistance was not a major issue. However, in 2013, tuberculosis remains a major public health concern worldwide, with prevalence of multidrug-resistant (MDR) tuberculosis rising. WHO estimates roughly 630 000 cases of MDR tuberculosis worldwide, with great variation in the frequency of MDR tuberculosis between countries. In the past 8 years, extensively drug-resistant (XDR) tuberculosis has emerged, and has been reported in 84 countries, heralding the possibility of virtually untreatable tuberculosis. Increased population movement, the continuing HIV pandemic, and the rise in MDR tuberculosis pose formidable challenges to the global control of tuberculosis. We provide an overview of the global burden of drug-resistant disease; discuss the social, health service, management, and control issues that fuel and sustain the epidemic; and suggest specific recommendations for important next steps. Visionary political leadership is needed to curb the rise of MDR and XDR tuberculosis worldwide, through sustained funding and the implementation of global and regional action plans.

AB - Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly cost-effective directly observed treatment short-course programme to control the epidemic. At that time, most strains of Mycobacterium tuberculosis were susceptible to first-line tuberculosis drugs, and drug resistance was not a major issue. However, in 2013, tuberculosis remains a major public health concern worldwide, with prevalence of multidrug-resistant (MDR) tuberculosis rising. WHO estimates roughly 630 000 cases of MDR tuberculosis worldwide, with great variation in the frequency of MDR tuberculosis between countries. In the past 8 years, extensively drug-resistant (XDR) tuberculosis has emerged, and has been reported in 84 countries, heralding the possibility of virtually untreatable tuberculosis. Increased population movement, the continuing HIV pandemic, and the rise in MDR tuberculosis pose formidable challenges to the global control of tuberculosis. We provide an overview of the global burden of drug-resistant disease; discuss the social, health service, management, and control issues that fuel and sustain the epidemic; and suggest specific recommendations for important next steps. Visionary political leadership is needed to curb the rise of MDR and XDR tuberculosis worldwide, through sustained funding and the implementation of global and regional action plans.

UR - http://www.scopus.com/inward/record.url?scp=84878434964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878434964&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(13)70030-6

DO - 10.1016/S1473-3099(13)70030-6

M3 - Article

C2 - 23531391

AN - SCOPUS:84878434964

VL - 13

SP - 529

EP - 539

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 6

ER -